Back to Journals » Biologics: Targets and Therapy » Volume 6

First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
13,298 | Dovepress* | 9,042 | 577+ | 2,374 | 9,619 |
PubMed Central* | 3 | 3,676 | 1,140 | 3,679 | |
Totals | 9,045 | 4,253 | 3,514 | 13,298 | |
*Since 25 September 2012 +Since July 2016 |
View citations on PubMed Central and Google Scholar